Kyverna Therapeutics, Inc. (KYTX) Reports Q1 Loss of $1.03
Tweet
Share
E-mailGet Alerts KYTX Hot Sheet
Join SI Premium – FREE
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) reported Q1 EPS of ($1.03).
For earnings history and earnings-related data on Kyverna Therapeutics, Inc. (KYTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Costco (COST) Tops Q4 EPS by 20c
- 22nd Century Group urges FDA to finalize nicotine reduction rule
- YYForce posts 26.8% revenue gain but widens net loss in H1 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
